Literature DB >> 16140788

Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment.

Tetsuro Ikegami1, Sungyong Won, C J Peters, Shinji Makino.   

Abstract

Analysis of purified Rift Valley fever virus (RVFV) particles demonstrated the presence of three negative-sense RNA genomes, plus three anti-viral-sense RNA segments. The virion-associated anti-viral-sense S segment served as a template for the synthesis of NSs mRNA immediately after infection. NSs protein synthesis also occurred early in infection, suggesting that NSs protein produced early in infection probably has biologically significant roles in virus replication and/or survival in the host. Translation inhibitor treatment of mammalian cells infected with viruses belonging to the Bunyaviridae family generally inhibits viral mRNA synthesis. However, RVFV NSs mRNA synthesis, but not N mRNA synthesis, was resistant to puromycin treatment during primary transcription, pointing to the uniqueness of RVFV NSs mRNA synthesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140788      PMCID: PMC1212623          DOI: 10.1128/JVI.79.18.12106-12111.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture.

Authors:  Gabriele Neumann; Heinz Feldmann; Shinji Watanabe; Igor Lukashevich; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system.

Authors:  Tetsuro Ikegami; C J Peters; Shinji Makino
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Analyses of the mRNA transcription processes of Punta Toro phlebovirus (Bunyaviridae).

Authors:  T Ihara; Y Matsuura; D H Bishop
Journal:  Virology       Date:  1985-12       Impact factor: 3.616

4.  Inhibitors of protein synthesis inhibit both La Crosse virus S-mRNA and S genome syntheses in vivo.

Authors:  R Raju; D Kolakofsky
Journal:  Virus Res       Date:  1986-07       Impact factor: 3.303

5.  Translational requirement for La Crosse virus S-mRNA synthesis: a possible mechanism.

Authors:  C Bellocq; D Kolakofsky
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

6.  Analyses of the mRNA transcription processes of snowshoe hare bunyavirus S and M RNA species.

Authors:  Y Eshita; B Ericson; V Romanowski; D H Bishop
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

7.  Cooperation of an RNA packaging signal and a viral envelope protein in coronavirus RNA packaging.

Authors:  K Narayanan; S Makino
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 8.  Rift Valley fever: an uninvited zoonosis in the Arabian peninsula.

Authors:  Hanan H Balkhy; Ziad A Memish
Journal:  Int J Antimicrob Agents       Date:  2003-02       Impact factor: 5.283

9.  NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription.

Authors:  Agnès Billecocq; Martin Spiegel; Pierre Vialat; Alain Kohl; Friedemann Weber; Michèle Bouloy; Otto Haller
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus.

Authors:  Nicolas Le May; Sandy Dubaele; Luca Proietti De Santis; Agnès Billecocq; Michèle Bouloy; Jean-Marc Egly
Journal:  Cell       Date:  2004-02-20       Impact factor: 41.582

View more
  51 in total

1.  Roles of the coding and noncoding regions of rift valley Fever virus RNA genome segments in viral RNA packaging.

Authors:  Shin Murakami; Kaori Terasaki; Krishna Narayanan; Shinji Makino
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture.

Authors:  Sungyong Won; Tetsuro Ikegami; C J Peters; Shinji Makino
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

3.  Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry.

Authors:  Brian H Bird; Marina L Khristova; Pierre E Rollin; Thomas G Ksiazek; Stuart T Nichol
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

4.  Bunyavirus mRNA synthesis is coupled to translation to prevent premature transcription termination.

Authors:  John N Barr
Journal:  RNA       Date:  2007-03-30       Impact factor: 4.942

Review 5.  Molecular aspects of Rift Valley fever virus and the emergence of reassortants.

Authors:  Natasha N Gaudreault; Sabarish V Indran; Velmurugan Balaraman; William C Wilson; Juergen A Richt
Journal:  Virus Genes       Date:  2018-11-13       Impact factor: 2.332

6.  Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR.

Authors:  Birte Kalveram; Olga Lihoradova; Sabarish V Indran; Nandadeva Lokugamage; Jennifer A Head; Tetsuro Ikegami
Journal:  Virology       Date:  2012-10-12       Impact factor: 3.616

7.  Molecular biology of rift valley Fever virus.

Authors:  Michele Bouloy; Friedemann Weber
Journal:  Open Virol J       Date:  2010-04-22

8.  Comparison of antiviral activity of recombinant and natural interferons against crimean-congo hemorrhagic Fever virus.

Authors:  Helen Karlberg; Gunnel Lindegren; Ali Mirazimi
Journal:  Open Virol J       Date:  2010-04-22

9.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

10.  Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.

Authors:  Tetsuro Ikegami; Krishna Narayanan; Sungyong Won; Wataru Kamitani; C J Peters; Shinji Makino
Journal:  PLoS Pathog       Date:  2009-02-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.